MedPath

Patient Education in the Clinical Management of Pessary

Not Applicable
Not yet recruiting
Conditions
Pelvic Organ Prolapse
Interventions
Other: video education
Other: conventional education
Registration Number
NCT06432218
Lead Sponsor
Peking Union Medical College Hospital
Brief Summary

This study is a prospective, randomized, controlled, single-blinded, multi-center clinical trial. Symptomatic patients with pelvic organ prolapse (POP) stage II, III or IV arranged to undergo pessary treatment will be randomized into either the experimental group or the control group. All patients will receive conventional verbal/paper instruction and counseling from a specialized doctor or nurse before pessary fitting, and the experimental group will receive additional patient education in the form of a re-watchable video. The video mainly includes a short introduction of pessary treatment for pelvic organ prolapse, tips and tricks for wearing and self-management of pessary, possible adverse reactions and remedy. All patients will receive regular pessary fitting and be followed up for 1 year. Self-assessment questionnaires will be used to assess the patients' willingness to pessary treatment, anxiety status, treatment satisfaction and efficacy, and to assess the patients' self-management, complications and treatment adherence. Then the differences between the two groups will be compared.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
280
Inclusion Criteria
  • Symptomatic pelvic organ prolapse of stage II~IV
  • Ability to participate in clinical trial and follow-up
  • The patient and family understand the study, are willing to participate in the 1-year study, and provide written informed consent
Exclusion Criteria
  • Acute phase of infection of the internal and/or external genital tracts
  • Genital fistula
  • Suspected or untreated lower genital tract tumors
  • Abnormally elevated intra-abdominal pressure (e.g., ascites, tumors)
  • Life expectancy less than 1 year
  • Cognitive or language communication disorders
  • Unable to watch video (e.g., blindness)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
the conventional education plus video education groupconventional educationWatch video as well as receive conventional guidance.
the conventional education plus video education groupvideo educationWatch video as well as receive conventional guidance.
the conventional education groupconventional educationReceive conventional guidance.
Primary Outcome Measures
NameTimeMethod
Continued usage with satisfaction12 months after pessary fitting.

Continued usage of the pessary and have very much or much improvement in the patient impression of improvement (PGI-I) questionnaire at 1 year.

Secondary Outcome Measures
NameTimeMethod
Willingness to treatmentBaseline, at pessary fitting, and 3 and 12 months after successful pessary fitting.

Self-rated score from 0 to 10 points (higher scores mean a better outcome).

Anxiety about pessary useBaseline and at pessary fitting.

7-item generalized anxiety disorder questionnaire (GAD-7) (the range of scores is 0-21, and higher scores mean a worse outcome), and self-rated score of sleep quality from 0 to 10 points (higher scores mean a better outcome).

Improvement in symptoms3 and 12 months after successful pessary fitting.

Pelvic floor impact questionnaire-7 (PFIQ-7) (the range of scores is 0-300, and higher scores mean a worse outcome)

Knowledge of pessaryBaseline and at pessary fitting.

Self-rated score from 0 to 10 points (higher scores mean a better outcome).

Ability to self-manage3 and 12 months after successful pessary fitting.

Self-rated score from 0 to 10 points (higher scores mean a better outcome).

Treatment-related symptoms and complications3 and 12 months after successful pessary fitting.

Self report and physical examination.

Improvement in quality of life3 and 12 months after successful pessary fitting.

Pelvic floor distress inventory-20 (PFDI-20) (the range of scores is 0-300, and higher scores mean a worse outcome)

Improvement in sexual activity3 and 12 months after successful pessary fitting.

The pelvic organ prolapse/urinary incontinence sexual questionnaire short form (PISQ-12) (the range of scores is 0-48, and higher scores mean a worse outcome)

Trial Locations

Locations (1)

Peking Union Medical College Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath